Roivant Sciences Ltd.

{
  "main_header": {
    "sid": 1282204,
    "name": "Roivant Sciences Ltd.",
    "stock_name": "Roivant Sciences Ltd.",
    "full_name": "Roivant Sciences Ltd.",
    "name_url": "stocks-analysis/roivant-sciences",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "22.58",
    "chg": -0.39,
    "chgp": "-1.7%",
    "dir": -1,
    "prev_price": "22.97",
    "mcapval": "15,982.40",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "BMG762791017",
    "curr_date": "Jan 23",
    "curr_time": "",
    "bse_nse_vol": "4.76 M",
    "exc_status": "Active",
    "traded_date": "Jan 23, 2026",
    "traded_date_str": "2026 01 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/roivant-sciences-1282204-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Roivant Sciences Hits New 52-Week High of $20.77, Up 94.9% Year-to-Date",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roivant-sciences-hits-new-52-week-high-of-2077-up-949-year-to-date-3686452",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RoivantSciences_priceRelatedfactors_3686452.png",
        "date": "2025-11-10 17:14:42",
        "description": "Roivant Sciences has achieved a new 52-week high of USD 20.77, reflecting a substantial year-over-year performance increase. As a small-cap company in the Pharmaceuticals & Biotechnology sector, it has a market capitalization of USD 8,816 million and showcases notable resilience despite its loss-making status."
      },
      {
        "title": "Roivant Sciences Hits New 52-Week High at $20.68, Up 94.42% Year-to-Date",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roivant-sciences-hits-new-52-week-high-at-2068-up-9442-year-to-date-3680170",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RoivantSciences_priceRelatedfactors_3680170.png",
        "date": "2025-11-07 16:05:44",
        "description": "Roivant Sciences has achieved a new 52-week high, reflecting significant growth over the past year. The company, with a market capitalization of USD 8,816 million, has outperformed the S&P 500. However, it remains loss-making, with a negative return on equity and no dividend yield, emphasizing its growth-oriented strategy."
      },
      {
        "title": "Roivant Sciences Hits New 52-Week High of $20.09, Up 88.94%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roivant-sciences-hits-new-52-week-high-of-2009-up-8894-3667304",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RoivantSciences_priceRelatedfactors_3667304.png",
        "date": "2025-11-03 17:10:29",
        "description": "Roivant Sciences achieved a new 52-week high of USD 20.09 on October 31, 2025, reflecting an impressive one-year performance of 88.94%. With a market capitalization of USD 8,816 million, the company faces challenges, including a negative return on equity and a competitive industry landscape."
      },
      {
        "title": "Roivant Sciences Hits New 52-Week High of $19.66, Up 85%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roivant-sciences-hits-new-52-week-high-of-1966-up-85-3661962",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RoivantSciences_priceRelatedfactors_3661962.png",
        "date": "2025-10-31 16:17:04",
        "description": "Roivant Sciences has achieved a new 52-week high, reflecting an impressive performance over the past year, significantly outpacing broader market growth. As a small-cap player in the Pharmaceuticals & Biotechnology sector, the company faces challenges, including a negative return on equity and a loss-making status, amidst its innovative strategies."
      }
    ],
    "total": 16,
    "sid": "1282204",
    "stock_news_url": "https://www.marketsmojo.com/news/roivant-sciences-1282204"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Roivant Sciences Hits New 52-Week High of $20.77, Up 94.9% Year-to-Date

2025-11-10 17:14:42

Roivant Sciences has achieved a new 52-week high of USD 20.77, reflecting a substantial year-over-year performance increase. As a small-cap company in the Pharmaceuticals & Biotechnology sector, it has a market capitalization of USD 8,816 million and showcases notable resilience despite its loss-making status.

Read full news article

Roivant Sciences Hits New 52-Week High at $20.68, Up 94.42% Year-to-Date

2025-11-07 16:05:44

Roivant Sciences has achieved a new 52-week high, reflecting significant growth over the past year. The company, with a market capitalization of USD 8,816 million, has outperformed the S&P 500. However, it remains loss-making, with a negative return on equity and no dividend yield, emphasizing its growth-oriented strategy.

Read full news article

Roivant Sciences Hits New 52-Week High of $20.09, Up 88.94%

2025-11-03 17:10:29

Roivant Sciences achieved a new 52-week high of USD 20.09 on October 31, 2025, reflecting an impressive one-year performance of 88.94%. With a market capitalization of USD 8,816 million, the company faces challenges, including a negative return on equity and a competitive industry landscape.

Read full news article

Roivant Sciences Hits New 52-Week High of $19.66, Up 85%

2025-10-31 16:17:04

Roivant Sciences has achieved a new 52-week high, reflecting an impressive performance over the past year, significantly outpacing broader market growth. As a small-cap player in the Pharmaceuticals & Biotechnology sector, the company faces challenges, including a negative return on equity and a loss-making status, amidst its innovative strategies.

Read full news article

View All News